Kazuko Aoyagi

Senior Director Business Development @Celerion

San Francisco, CA, US
EMAILS
k••••••••@celerion.com
MOBILE NUMBERS
+16•••••••28

Signup · Get unlimited contacts

WORK HISTORY

May 2016 — Present

Senior Director Business Development @Celerion

View department →

I manage Japanese and Asian accounts for Celerion. We focus on the implementation of innovative strategies to generate key data very early, to enable go/no-go decisions in drug development.

EDUCATION

2000 — 2001

Massachusetts Institute of Technology

Pharmacology, Molecular Medicine

1981 — 1985

University of California, Berkeley

PhD, Plant molecular biology

SKILLS

CROLife SciencesDrug DevelopmentGcpGlpDrug DiscoveryMolecular BiologyClinical DevelopmentAssay DevelopmentCRO ManagementBiotechnologyHplcResearch and Development (R&D)Regulatory SubmissionsR&DMedical DevicesClinical ResearchGeneticsBiomarkersChromatographyPharmacologyBioinformaticsCtmsPcrPharmaceutical IndustrySopClinical TrialsValidationRegulatory AffairsLifesciencesGenomics

ABOUT KAZUKO AOYAGI

Celerion is the privately owned CRO formed through the acquisition of the development and regulatory services consultancy and early clinical development operations of MDS Pharma Services. My role is to assist sponsors make a Go, No Go decisions early by facilitating discussion with our experts.Specialties: The focus of the company is providing comprehensive early clinical research and bioanalytical services to the drug development community.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.